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Abstract
Background: Magnetic Resonance Spectroscopic Imaging (MRSI) has wide applicability for non-invasive biochemical
assessment in clinical and pre-clinical applications but suffers from long scan times. Compressed sensing (CS) has been
successfully applied to clinical 1H MRSI, however a detailed evaluation of CS for conventional chemical shift imaging is
lacking. Here we evaluate the performance of CS accelerated MRSI, and specifically apply it to accelerate 23Na-MRSI on
mouse hearts in vivo at 9.4 T.
Methods: Synthetic phantom data representing a simplified section across a mouse thorax were used to evaluate
the fidelity of the CS reconstruction for varying levels of under-sampling, resolution and signal-to-noise ratios (SNR).
The amplitude of signals arising from within a compartment, and signal contamination arising from outside the
compartment relative to noise-free Fourier-transformed (FT) data were determined. Simulation results were subsequently
verified experimentally in phantoms and in three mouse hearts in vivo.
Results: CS reconstructed MRSI data are scaled linearly relative to absolute signal intensities from the fully-sampled FT
reconstructed case (R2 > 0.8, p-value < 0.001). Higher acceleration factors resulted in a denoising of the reconstructed
spectra, but also in an increased blurring of compartment boundaries, particularly at lower spatial resolutions. Increasing
resolution and SNR decreased cross-compartment contamination and yielded signal amplitudes closer to the FT data.
Proof-of-concept high-resolution, 3-fold accelerated 23Na-amplitude maps of murine myocardium could be obtained
within ~23 mins.
Conclusions: Relative signal amplitudes (i.e. metabolite ratios) and absolute quantification of metabolite concentrations
can be accurately determined with up to 5-fold under-sampled, CS-reconstructed MRSI. Although this work focused on
murine cardiac 23Na-MRSI, the results are equally applicable to other nuclei and tissues (e.g. 1H MRSI in brain). Significant
reduction in MRSI scan time will reduce the burden on the subject, increase scanner throughput, and may open new
avenues for (pre-) clinical metabolic studies.
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Background
Magnetic Resonance Spectroscopic Imaging (MRSI) al-
lows non-invasive investigation of regional metabolic
processes in vivo, but suffers from long scan-times due
to low metabolite concentrations, slow spatial encoding
schemes, and low MR sensitivity (for nuclei other than
protons). This versatile technique would benefit from a
reduction in scan-time in order to make it more clinically
applicable. Single- or multi-shot echo-planar spectro-
scopic imaging (EPSI) sequences [1-6] have been proposed
to reduce MRSI scan-time. Indeed, Furuyama et al. have
evaluated the performance of CS EPSI based 2D J-resolved
spectroscopy [7,8]. However, EPSI is known to provide
lower sensitivity compared to classical chemical shift im-
aging (CSI) [7]. Low metabolite concentrations and re-
duced MR sensitivity limit the applicability of parallel
imaging. Conversely, Compressed Sensing (CS) is a tech-
nique for accelerating the inherently slow data acquisition
process, and is well suited for MRSI due to its intrinsic
denoising effect [9]. CS has been used to accelerate 1H-
[10,11], hyperpolarized 13C- [12-14],23Na- [15], 31P-MRSI
[16], and multi-dimensional NMR experiments [17,18].
The scan time reductions ranged from 2- [15,13] to 18-
fold [14]. The application of CS to (pre-) clinical in vivo
imaging necessitates thorough examination of the condi-
tions under which it is robust. However, little systematic
evaluation of the influence of SNR and spatial resolution
on the achievable scan-time reductions and quantification
of metabolite signals has been performed to date [7,13,19].
Whilst the work by Geethanath et al. [11] made an im-
portant step forward in the use of CS-MRSI, it generated
some debate regarding the reliability of its use in the clinic
[20,21]. We present a detailed performance evaluation of
the CS-reconstruction developed by Geethanath et al. in
the context of 1H-MRSI [11]. For the first time we then
apply CS to 23Na-MRSI on mouse hearts demonstrating




An in-silico noise-free phantom containing five compart-
ments and representing a simplified mouse thorax was
constructed in the image domain (256 × 256 voxels). Each
compartment contained a single Lorentzian resonance at
a unique frequency (Fig. 1a,b). This enabled quantification
of inter-compartment signal contamination arising from
CS reconstruction as the spatial origin of the signal could
be determined from its frequency. These data were Fou-
rier transformed (FT) into the time domain and the cen-
tral N ×N k-space points (N = 16, 24, 32, 48, 64) taken as
low-resolution representations. Gaussian noise was added
to vary the SNR in the image domain (2, 4, 8, 16, 32, 64,
128, 256 and ∞ (i.e. noise-free)), where SNR was defined
as the ratio of peak-height to the standard deviation of the
noise of the real part of the spectrum.
Hardware
All 23Na-MRSI data were acquired on a horizontal 9.4 T
MR system equipped with a VnmrS Direct Drive2 con-
sole and 60 mm i.d. 1 T/m imaging gradients (Agilent
Technologies, USA). An actively decoupled 23Na quad-
rature birdcage transmit resonator (i.d. 39 mm) was used
in combination with a 14 mm square surface receive coil
(Rapid Biomedical, Germany). 1H anatomical images
were acquired using a 39 mm quadrature birdcage res-
onator (Rapid Biomedical, Germany).
Fig. 1 Layout of phantoms. a Layout of the virtual phantom. Five compartments were defined within the phantom representing aorta,
myocardium, skeletal muscle, liver, and left ventricular blood pool (ROI1-5 respectively) with relative amplitudes of 5, 3, 1, 2, and 4. b The spectra
corresponding to voxels within each compartment contain a single Lorentzian resonance at a unique frequency. Example spectra from each
compartment within the virtual phantom, reconstructed at 64 × 64 voxels, are shown. Resonance frequencies for ROI1-5 were −1000, −500, 0, 500,
1000 Hz, respectively, with a T2
* of 50 ms. All spectra are plotted using the same axes. The small peak visible at −1000 Hz in ROI2 corresponds to
signal contamination from ROI5. c 1H-MR image of the experimental phantom containing NaCl solutions (inner compartment: 20 mM NaCl; outer
compartment: 100 mM NaCl). The two coaxial compartments on the left and right of the phantom contained 200 and 500 mM NaCl, respectively,
and served as concentration references. The area used for data normalization is indicated by the dashed line (3.3 x 3.5 mm ROI), and the position
of the surface coil used for 23Na signal reception is shown
Maguire et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:45 Page 2 of 9
Phantom experiments
Validation experiments were conducted on a phantom
comprised of two coaxial compartments with the inner
compartment (i.d. 3.6 mm, volume ~ 1 ml) containing
20 mM NaCl, and the outer compartment (i.d. 13.5 mm,
volume 15 ml) containing 100 mM NaCl (Fig. 1c). The
phantom also contained two coaxial concentration refer-
ences containing 200 and 500 mM NaCl, which, how-
ever, were not used for this study. Fully sampled, single
average, 2D axial slice-selective MRSI data (60° flip
angle, 30 × 30 mm FOV, 2 mm slice, 96 × 96 PE steps,
TR/TE = 150/0.50 ms, 9216 FIDs, acquisition time ~24
mins) were acquired and repeated 32 times (total acqui-
sition time: 12.8 h). The central N ×N k-space points
(N = 16, 24, 32, 48, 64, 96) from multiple repetitions
were combined to give MRSI data sets with varying
spatial resolution and SNR.
In vivo experiments
Cardiac 23Na-MRSI experiments were conducted on three
female wild-type C57BL/6 mice (body weight 27.5 ± 4.0 g).
After induction of anaesthesia (4 % isoflurane in 100 %
oxygen), mice were positioned prone in a dedicated animal
cradle with the heart centred over the surface coil, and
maintained at 37 °C and 1.5–2.0 % isoflurane in 2 L/min
oxygen flow throughout the MRSI experiments. Cardiac
and respiratory signals were continuously monitored using
an in-house developed ECG and respiratory gating device
[22]. All investigations were approved by the local ethical
review committee and conformed to the Animals (Scien-
tific Procedures) Act 1986 (UK) incorporating European
directive 2010/63/EU.
Using the same MRSI sequence as for the phantom
data, threefold prospectively under-sampled 23Na data
were acquired in mouse hearts in vivo in short-axis
orientation (FOV 30 × 30 mm, 64 × 64 PE steps, 2 mm
slice thickness, 8 averages, 40° flip angle, cardiac trig-
gered, TR/TE = ~125/0.85 ms (i.e. one cardiac cycle),
total acquisition time ~23 mins). Under-sampling was
carried out as described previously [11].
Data analysis
All data were reconstructed and analysed in Matlab2013a
(Mathworks, USA). Synthetic and acquired phantom
data were retrospectively 1- to 5-fold under-sampled
using a pseudo-random sampling scheme and recon-
structed using a CS reconstruction described previously
[11]. Signal amplitudes (i.e. peak maximum of the real
component of the complex spectra), and contamination
for CS reconstructed data and fully-sampled, FT recon-
structed, data were compared. Signal amplitudes ob-
tained from the CS reconstructed data were subject to
linear regression analysis with the FT reconstructed
fully-sampled data. A p-value of < 0.05 indicated a
statistically significant correlation between the datasets.
Signal contamination, defined as the total signal ampli-
tude from resonances originating from outside the ROI
detected within the ROI divided by the number of vox-
els in the ROI, was assessed for the synthetic phantom
only. The 23Na myocardium/blood-ratio was estimated
in vivo by calculating the mean ratio from six pairs of
adjacent voxels located in the myocardium and the left
ventricular blood-pool. Ratios are quoted as mean ±
standard deviation. SNR was calculated for the myocar-
dium by dividing the amplitude of the 23Na resonance
in the spectrum by the standard deviation of the real
component of the noise between 10–20 ppm, distant
from the 23Na resonance; the chemical shift of the 23Na
resonance was defined as 0 ppm.
Results
Typical CS reconstructed data from the virtual phantom
(SNR = 32, 32 PE steps) are shown in Fig. 2, demonstrat-
ing similar spatial and relative signal intensity distribu-
tion to the FT data. Consistent with previous studies
[13], low SNR (i.e. ≤ 8) resulted in an exaggerated noise
floor in the CS reconstructed data preventing the recon-
struction from converging; these data were excluded
from further analysis. Although absolute signal inten-
sities relative to the fully-sampled noise-free FT recon-
structed case were not preserved, CS reconstruction
resulted in a linear scaling of the data (right column in
Fig. 2). Importantly, all CS reconstructed data demon-
strated a high correlation with FT reconstructed noise-
free fully-sampled data, with gradients ranging from 1.30
(R = 4, PE = 16, SNR = 16) to 5.73 (R = 1, PE = 64, SNR =
32), R2 values from 0.80 (R = 4, PE = 16, SNR = 16) to 0.98
(R = 1, PE = 64, SNR =∞), and p-value always <0.001.
Higher acceleration factor resulted in denoising of the
reconstructed spectra, but also in increased blurring of
compartment boundaries, particularly at lower resolu-
tions. This is qualitatively illustrated by the boundary of
ROI3 (Fig. 3). While the FT reconstruction of the fully
sampled data yielded the sharpest transition from signal
within ROI3 to the outside, oscillations in signal ampli-
tude outside the compartment are visible as a result of
the point-spread-function of the uniformly weighted ac-
quisition. Conversely, CS reconstructions of (R = 1 or 3)
reduced these oscillations at the boundary transition, but
resulted in an increased near-constant signal-floor out-
side the compartment, which decreased with improving
spatial resolution.
Figure 4 shows the color-coded (a,b; top row) signal
amplitude and (c,d; bottom row) contamination for
ROI2-4 of the virtual phantom, normalized to the mean
signal intensity from ROI1. Data were normalized to the
signal from ROI1 as this compartment provided a de-
fined signal and had dimensions similar to those that
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would be expected from a concentration reference phan-
tom that could reasonably used in murine cardiac in vivo
experiments. Data are presented as a function of spatial
resolution, acceleration factor, and SNR for the CS- (a, c;
left column) and the FT-reconstructions (b, d; right col-
umn). Unsurprisingly, the highest contamination, and
correspondingly lower signal amplitudes were found for
the CS reconstructed data of ROI2 (representing left-
ventricular myocardium) at low resolution. Similarly,
low amplitudes and high contamination were found for
CS reconstructions of all ROIs at lowest SNR and in-
creasing under-sampling factors. Increasing SNR and
resolution resulted in CS reconstructions that more
closely resembled the FT reconstruction of fully sampled
data, while contamination decreased to levels lower than
in those for the FT reconstruction.
In Fig. 5, sodium intensity maps from the compartmen-
ted phantom are shown for FT reconstructed fully-
sampled, and CS-reconstructed data (R = 1, 3 and 5; 32 PE
steps). The gradient in signal intensities along the vertical
axis of the images reflects the receive profile of the sur-
face coil. Horizontal and vertical profile, correlation
plots (normalized FT vs. CS reconstructed data), and
Bland-Altman analysis for the amplitudes confirmed the
behaviour observed in the virtual phantom: CS recon-
struction resulted in a high correlation between CS and
Fig. 2 Example reconstruction of virtual phantom. Normalized signal amplitude maps (PE = 32, SNR = 32) are shown in the left column for (a) FT
reconstructed fully-sampled data, and CS reconstructed data for (b) R = 1, (c) R = 3, and (d) R = 5. Example spectra from ROI2 and ROI3 are shown
in the middle two columns. The ROI from which each resonance originates is indicated above the spectra. Due to blurring of compartment
boundaries, there is signal contamination from compartments 3 and 5 evident in the spectrum for compartment 2; likewise the signal amplitude
of the peaks in compartment 2 is reduced relative to the FT data. Note the denoising effect of the CS reconstruction as acceleration factor
increases. All images and all spectra are plotted on the same scale. Correlation plots of FT reconstructed noise-free signal amplitudes against raw
CS reconstructed amplitudes (i.e. not normalized) for the same data are depicted in the right column for R = 1, 3 and 5. Linear regression yielded
slopes of 2.52, 2.61 and 2.53, with R2 values of 0.96, 0.96, and 0.94, respectively. All correlation plots share the same horizontal axis
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FT reconstructed data, in signal denoising, and in in-
creased blurring of compartment boundaries with in-
creased under-sampling.
A prospectively 3-fold under-sampled, CS-reconstructed,
myocardial 23Na-map in short-axis orientation obtained in
vivo from a mouse overlaid on an anatomical 1H-image,
and corresponding spectra, are presented in Fig. 6. Blood/
myocardium amplitude ratios of 0.45 ± 0.07, 0.48 ± 0.09,
and 0.47 ± 0.08 were obtained in vivo; assuming a blood
23Na concentration of ~79 mM [23], myocardial 23Na con-
centrations of 35.6, 37.9, and 37.1 mM can be estimated
for the three experiments. The SNR in the anterior myo-
cardium (close to the surface coil) was 42.1 ± 1.1, 49.2 ±
1.4, and 75.1 ± 1.8 (mean ± SD) whilst in the posterior
myocardium (distant from the surface coil) it was 36.6 ±
1.3, 36.5 ± 2.4, and 61.2 ± 1.5 (mean ± SD), respectively.
Discussion and conclusions
MRS(I) provides a unique method for investigation of
metabolic processes in living tissue and has been suc-
cessfully applied in clinical studies of brain and cancer
metabolism (e.g. [24-26]). Specifically, 23Na-MRSI has
the potential to monitor myocardial ion homeostasis in
models of cardiac disease. Widespread application of
MRSI remains limited, especially in the clinic, due to
significant technical challenges, low sensitivity and asso-
ciated long scan-times. A reduction in acquisition time
without sacrificing accuracy would represent an import-
ant step towards making MRSI more widely applicable.
The CS algorithm used in this work has been applied
previously to study brain and prostate tumours with
1H-MRSI [11], however our study offers several novel
aspects. By providing a thorough validation of the recon-
struction, we sought to determine the (pre-) clinical ap-
plicability of CS-accelerated MRSI. The use of synthetic
data ensured that the results were generally applicable,
independent of organ/tissue and nucleus. It also permitted
an assessment of cross-compartment signal contamin-
ation, which is not possible with (noise-free model of)
clinical data where compartments share similar metabolite
populations. To the best of our knowledge, only one study
has reported the application of 23Na-MRSI to murine
Fig. 3 Effect on spatial resolution of CS reconstruction. Mean signal profiles at the boundary of compartment 3 of the virtual phantom as an
illustration of the point-spread function using (a) 16, (b) 32, and (c) 64 phase encoding steps are shown for FT reconstruction (bold black line)
and CS reconstructions with R = 1, 3 and 5 (red, purple, and blue lines respectively). The profile from equivalent acquisition-weighted (Hanning)
FT reconstructed MRSI data is included for comparison (dotted line). All data are normalized to a maximum amplitude of 1.0
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hearts in vivo [27]. 23Na-MR spectroscopy commonly uti-
lises only a single resonance arising from both intra- and
extra-cellular sodium, which may therefore also be de-
tected with MR imaging. However, we used this nucleus to
prove the concept of the technique, with the ultimate aim
of combining it with multiple-quantum filters to distinguish
intra- from extra-cellular sodium. Thus, application of CS
to 23Na-MRSI could significantly reduce scan-time making
metabolic data acquisition possible within clinically accept-
able times.
There are several technical challenges to be faced in
applying CS to 23Na-MRSI of (murine) cardiac tissue:
large sodium concentration differences between tissues,
and thus MRSI signal intensity variations, lie in close
proximity (e.g. blood vs. myocardium vs. lungs), which
can be difficult to reconstruct using CS; the influence of
SNR and spatial resolution on CS reconstruction fidelity
had to be characterized.
Virtual phantom data, which mimicked the appearance
and challenges of an in vivo cross-section through a
Fig. 4 Signal amplitude and contamination for virtual phantom reconstructions. Mean signal amplitude from within an ROI normalized to the
mean signal of ROI1 is plotted against number of phase encoding steps (Res; PE = 16, 24, 32, 48, 64), ROI number (ROI; 2–5), acceleration factor
(R; 1–5), and SNR (∞, 256, 128, 64, 32, and 16) for (a) CS and (b) FT reconstructions; plots share the same scale. The CS plot (a) is divided into 5×4
element rectangles, each corresponding to CS reconstructions at a given SNR/spatial resolution. Columns correspond to acceleration factor
(R = 1-5; left to right) and rows to ROI2-5 (top to bottom). SNR decreases towards the right and resolution increases towards the bottom. The FT
plot (b) is divided into 6×4 element rectangles, each rectangle corresponding to FT reconstructions carried out at a given spatial resolution;
columns correspond to SNR (∞, 256, 128, 64, 32, and 16; left to right) and rows to ROI2-5 (top to bottom). The number of phase encoding steps
increases towards the bottom of the plot. Triangles below/left of the plots indicate parameter magnitude with the thin end corresponding to the
lowest value. If a CS reconstruction performs identically to the equivalent FT reconstruction, then the column of the CS plot (a) should appear
identical to the corresponding column of the FT plot (b). Mean signal contamination arising from outside an ROI detected within that ROI
normalized to the mean signal from ROI1 is plotted against number of phase encoding steps, ROI number, CS acceleration factor, and SNR for
both (c) CS and (d) FT reconstructions; plots share the same scale. Interpretation of the plots is analogous to that of the amplitude plots above.
Increasing SNR and decreasing acceleration factor improves agreement between CS and FT reconstructions. Note the separate scale bars for
amplitude and contamination plots
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murine thorax, was used to characterize CS performance.
For ROI2 (left-ventricular myocardium) this resulted in a
wall thickness of between 1 and 3 voxels corresponding
to ~0.5-1.5 mm in typical in vivo mouse cardiac MRSI
experiment. We found that absolute signal amplitudes
following CS reconstruction were not preserved, but cor-
related linearly with those obtained in the (noise-free)
conventional FT reconstruction (i.e. “ground truth”). This
finding has two immediate implications. Firstly, linear
scaling of the amplitude means relative amplitudes (i.e.
metabolite ratios) remain unaffected by CS reconstruction.
Consequently, absolute quantification of metabolite con-
centration relative to a signal from a compartment of
known concentration remains accurate. Secondly, the cal-
culation of root-mean-square errors, which are typically
used as a measure of data fidelity, would yield high values
and not reflect the quality of the reconstruction. Thus re-
constructed signal amplitudes and signal contamination,
normalized to the mean signal intensity from a defined
ROI, were chosen as metrics for this purpose (Fig. 4). For
the CS reconstructions, increasing spatial resolution re-
duced signal contamination (bottom row, Fig. 4) and
Fig. 5 CS reconstruction of retrospectively under-sampled phantom data. Results of CS reconstruction of retrospectively under-sampled phantom
CSI data acquired with one average and 32 × 32 PE steps. Images represent the signal amplitude (magnitude-modulated by the receive profile of
the surface coil, the position of which is indicated in the top left panel) following FT reconstruction of fully-sampled data, and CS reconstruction
of data with R = 1, 3, and 5 (top to bottom). All images are plotted on the same scale. The white dashed lines in the top left panel illustrate the
position of the displayed profiles (second column from left); solid and dashed lines indicate vertical and horizontal profiles, respectively. Note the
reduction in noise around the phantom arising from the CS reconstruction for R = 1 relative to the FT reconstruction and smoother profiles
across the phantom. Increasing acceleration factor and decreasing SNR resulted in blurring of the boundaries of the phantom in the images.
The third column shows the correlation between the normalized signal amplitude of fully-sampled FT reconstructed data (x-axis) and of the CS
reconstructed under-sampled data (y-axis); data were normalized to the mean signal arising from the ROI indicated in Fig. 1c. Linear regression
yielded slopes of 1.09, 0.98, and 0.88, with R2 values of 0.98, 0.96, and 0.89, respectively. The right-hand column shows Bland-Altman plots for
normalized FT- and CS-reconstructed signal amplitudes. The mean difference in signal amplitude is indicated by a solid line, and 95 % confidence
interval by dashed lines. The value of the mean difference in amplitude is indicated on the plots. All plot amplitudes are in arbitrary units
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blurring of compartment boundaries (Fig. 3). Low-
resolution FT reconstructed data yielded signal oscilla-
tions inside and outside the compartment due to convolu-
tion of the image with the FT of a step function. CS
reconstruction reduced these oscillations at the cost of
near-constant signal level outside the compartment, which
increased with higher under-sampling factors and/or de-
creasing resolution. Whilst there is a straightforward rela-
tionship between data sampling and point spread function
for FT reconstruction, the relationship is more complex
for CS. The CS reconstruction used here assumes that an
image consists of regions of approximately homogeneous
signal with relatively sharp discontinuities in signal inten-
sity between regions, and that the resulting reconstruction
must be consistent with the acquired k-space data. These
assumptions give rise to some blurring of the boundaries
between homogeneous regions resulting in an apparent
loss of spatial resolution and out-of-voxel signal contam-
ination. Some understanding of the origins of a signal can
be inferred from the spatial distribution of the recon-
structed signal across a sharp boundary, for example at
the edge of a phantom where the signal transitions from
that originating from within the phantom to the void
surrounding the phantom. Signal present in the void sur-
rounding the phantom indicates of out-of-voxel contam-
ination present in that voxel; Fig. 3 demonstrates this
effect of CS and reveals that the out-of-voxel contamin-
ation approaches that present in FT reconstructed data as
spatial resolution increases. CS can result in low-level
signal contamination arising from signals a considerable
distance outside the target voxel.
Our findings suggest in agreement with the literature
[11], that up to 5-fold under-sampling of (pre-)clinical
MRSI will be possible without significant impact on data
fidelity given modest SNR. This conclusion was subse-
quently confirmed in retrospectively under-sampled
phantom experiments. Prospectively accelerated in vivo
data were also acquired. Notably, our murine study was
at the lower end of the SNR requirements due to the very
high spatial resolution; Neuberger et al. report that a voxel
volume of 1 mm3 could be achieved within ~90 mins [27],
which was over twice the volume used in our study. Thus,
a conservative under-sampling factor of 3 was chosen
in vivo. Additionally, the reconstruction of the phantom
and in vivo data demonstrated that CS accurately repro-
duces spatially inhomogeneous signals arising from the re-
ceive profile of the surface coil used to acquire the data.
The quantified myocardium/blood amplitude ratios agreed
well with previously reported values of 0.42 ± 0.15 for
mouse [27] and 0.57 for humans [23]. A 3-fold reduction
in scan time to ~23 mins for a single slice makes our
protocol suitable for use as part of a multi-parametric
MR-phenotyping investigation, or to study severely sick
animals by reducing the anaesthetic burden. Assuming
that the typical mouse heart is approximately 8 mm in
length, full heart coverage using 2D CS-MRSI as described
would therefore take ~92 mins; this represents half
the voxel volume described by Neuberger et al. within
the same scan time. Furthermore, use of through-plane
sparsity information in the CS reconstruction should allow
further acceleration of 2D multislice or 3D CS-MRSI
without loss of reconstruction fidelity. Compressed sens-
ing has undoubtedly a significant role to play in the future
of preclinical and clinical MRSI. Increases in total tissue
sodium concentration of between 150 and 330 % have
been observed for a variety of pathologies [28-31]. Fig. 3
would suggest that for resolutions at or above 32 × 32
PE steps, the level of potential signal contamination in a
voxel arising from CS reconstruction would have an ap-
proximate upper limit of 20 %. However, in the presence
of this level of signal contamination, such pathologies
should be detectable. In general, the SNR of the data
will fundamentally limit the ability to detect patho-
logical abnormalities; whilst FT performs better than CS
at very low SNR, accurate data fitting/quantification
under these conditions may prove limiting even for FT
reconstruction. Whilst the experimental results pre-
sented here focus on MRSI and its application to 23Na,
the simulation results apply equally well to 1H, 31P,
or 13C MRSI. Prospectively under-sampling data can
Fig. 6 Representative in vivo CS three-fold accelerated cardiac MRSI. CS reconstructed prospectively under-sampled 23Na CSI (R = 3) of a murine
heart in short-axis orientation (colour) overlaid onto a 1H anatomical image (black and white). The position of the surface coil is indicated. The
concentration reference phantom (CR) has been omitted from the CSI data. The difference in Na concentration between the myocardium and
blood pool is clearly reflected in the color-coded signal amplitudes of the 23Na image. Example phased spectra for the myocardium (*) and left
ventricular blood (+) are shown on the right. Both spectra are plotted on the same scale
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significantly reduce MRSI data acquisition to a clinically
acceptable time, reducing the burden on the patient and
increasing scanner throughput without sacrificing diag-
nostic accuracy.
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